285 related articles for article (PubMed ID: 9167953)
21. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
DeLellis RA
Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
[No Abstract] [Full Text] [Related]
22. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
23. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
[TBL] [Abstract][Full Text] [Related]
24. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
25. Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma.
Koch CA; Huang SC; Moley JF; Azumi N; Chrousos GP; Gagel RF; Zhuang Z; Pacak K; Vortmeyer AO
Oncogene; 2001 Nov; 20(53):7809-11. PubMed ID: 11753660
[TBL] [Abstract][Full Text] [Related]
26. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
27. Familial neuroendocrine tumors as a model of hereditary cancer.
Anderson RJ; Lynch HT
Curr Opin Oncol; 1997 Jan; 9(1):45-54. PubMed ID: 9090493
[TBL] [Abstract][Full Text] [Related]
28. RET proto-oncogene in the development of human cancer.
Eng C
J Clin Oncol; 1999 Jan; 17(1):380-93. PubMed ID: 10458257
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
Eng C; Mulligan LM
Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
Donis-Keller H; Dou S; Chi D; Carlson KM; Toshima K; Lairmore TC; Howe JR; Moley JF; Goodfellow P; Wells SA
Hum Mol Genet; 1993 Jul; 2(7):851-6. PubMed ID: 8103403
[TBL] [Abstract][Full Text] [Related]
31. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
[TBL] [Abstract][Full Text] [Related]
32. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
Carlson KM; Dou S; Chi D; Scavarda N; Toshima K; Jackson CE; Wells SA; Goodfellow PJ; Donis-Keller H
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1579-83. PubMed ID: 7906417
[TBL] [Abstract][Full Text] [Related]
33. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
35. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
[TBL] [Abstract][Full Text] [Related]
36. Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
McMahon R; Mulligan LM; Healey CS; Payne SJ; Ponder M; Ferguson-Smith MA; Barton DE; Ponder BA
Hum Mol Genet; 1994 Apr; 3(4):643-6. PubMed ID: 7915166
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
Sánchez B; Robledo M; Biarnes J; Sáez ME; Volpini V; Benítez J; Navarro E; Ruiz A; Antiñolo G; Borrego S
J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371
[TBL] [Abstract][Full Text] [Related]
38. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
39. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
[TBL] [Abstract][Full Text] [Related]
40. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
